长期非编码的HOXA-AS3通过miR-1286/TEAD1轴促进骨髓瘤的进展
Xiangjun Xiao1, Mingjiang Liu2, Songlin Xie1
1Department of Hand and Foot Surgery, Nanhua Hospital Affiliated to Nanhua University, Hengyang, 421002, China.
Journal of orthopaedic surgery and research
|September 26, 2023
概括
长非编码RNAHOXA-AS3通过增加扩散,迁移和入侵来促进骨髓瘤 (OS) 的进展. 针对HOXA-AS3/miR-1286/TEAD1轴为骨髓瘤提供了一个潜在的治疗策略.
科学领域:
- 分子生物学分子生物学
- 在瘤学瘤学.
- 遗传学 遗传学 是一个
背景情况:
- 长非编码RNAs (lncRNAs) 越来越多地被认为是它们在癌症中的作用.
- 在骨髓瘤 (OS) 中,HOXA集群抗意义RNA 3 (HOXA-AS3) 的特定功能尚不清楚.
研究的目的:
- 研究HOXA-AS3在骨髓瘤进展中的作用和潜在机制.
- 探索HOXA-AS3作为OS的潜在治疗点.
主要方法:
- 对OS组织和细胞系中HOXA-AS3表达的分析.
- 在体外和体内实验中涉及HOXA-AS3沉默在OS细胞的实验.
- 研究竞争的内源RNA (ceRNA) 网络,其中包括HOXA-AS3,miR-1286和TEAD1.
主要成果:
- 在OS组织中,HOXA-AS3的调节升高,并与不良的临床结果相关.
- 沉默HOXA-AS3抑制了OS细胞的增殖,迁移,入侵和瘤发生.
- 在OS中,HOXA-AS3通过通过海绵化miR-1286.6对TEAD1进行上调来促进细胞的增殖,迁移和上皮细胞转移到介质细胞 (EMT).
结论:
- HOXA-AS3/miR-1286/TEAD1轴在骨髓瘤进展中起着至关重要的瘤作用.
- 在骨髓瘤治疗中,HOXA-AS3 是一个有前途的治疗点.
相关概念视频
lncRNA - Long Non-coding RNAs
8.6K
In humans, more than 80% of the genome gets transcribed. However, only around 2% of the genome codes for proteins. The remaining part produces non-coding RNAs which includes ribosomal RNAs, transfer RNAs, telomerase RNAs, and regulatory RNAs, among other types. A large number of regulatory non-coding RNAs have been classified into two groups depending upon their length – small non-coding RNAs, such as microRNA, which are less than 200 nucleotides in length, and long non-coding RNA...
8.6K
Tumor Progression
6.4K
Tumor progression is a phenomenon where the pre-formed tumor acquires successive mutations to become clinically more aggressive and malignant. In the 1950s, Foulds first described the stepwise progression of cancer cells through successive stages.
Colon cancer is one of the best-documented examples of tumor progression. Early mutation in the APC gene in colon cells causes a small growth on the colon wall called a polyp. With time, this polyp grows into a benign, pre-cancerous tumor. Further...
Colon cancer is one of the best-documented examples of tumor progression. Early mutation in the APC gene in colon cells causes a small growth on the colon wall called a polyp. With time, this polyp grows into a benign, pre-cancerous tumor. Further...
6.4K
MicroRNAs
3.0K
MicroRNA (miRNA) are short, regulatory RNA transcribed from introns (non-coding regions of a gene) or intergenic regions (stretches of DNA present between genes). Several processing steps are required to form biologically active, mature miRNA. The initial transcript, called primary miRNA (pri-mRNA), base-pairs with itself, forming a stem-loop structure. Within the nucleus, an endonuclease enzyme, called Drosha, shortens the stem-loop structure into hairpin-shaped pre-miRNA. After the pre-miRNA...
3.0K
Loss of Tumor Suppressor Gene Functions
4.9K
Tumor suppressor genes are normal genes that can slow down cell division, repair DNA mistakes, or program the cells for apoptosis in case of irreparable damage. Hence, they play an essential role in preventing the proliferation of damaged cells.
When the tumor suppressor genes develop mutations or are lost, cells start growing out of control, leading to cancer. However, a single functional copy of the tumor suppressor gene is enough for the cells to maintain their normal functions and cell...
When the tumor suppressor genes develop mutations or are lost, cells start growing out of control, leading to cancer. However, a single functional copy of the tumor suppressor gene is enough for the cells to maintain their normal functions and cell...
4.9K
PI3K/mTOR/AKT Signaling Pathway
3.6K
The mammalian target of rapamycin (mTOR) is a serine/threonine kinase that regulates growth, proliferation, and cell survival in response to hormones, growth factors, or nutrient availability. This kinase exists in two structurally and functionally distinct forms: mTOR complex 1 (mTORC1) and mTOR complex 2 (mTORC2). The first form (mTORC1) is composed of a rapamycin-sensitive Raptor and proline-rich Akt substrate, PRAS40. In contrast, mTORC2 consists of a...
3.6K
TGF - β Signaling Pathway
7.4K
The TGF-β signaling pathway regulates cell growth, differentiation, adhesion, motility, and development. TGF-β ligands that induce TGF-β signaling are synthesized in their latent form. Several proteases or cell surface receptors such as integrins act upon the latent form, releasing the active ligand. There are three types of mammalian TGF-βs: (TGF-β1, TGF-β2, and TGF-β3) that bind as homodimers or heterodimers to TGF-β receptors. The TGF-β receptors...
7.4K


